Syneos Health Acquires Kinapse

August 20, 2018

Applied Clinical Trials

Syneos Health, Inc., a biopharmaceutical solutions organization, announced the acquisition of Kinapse, a market advisory and operational solutions provider, from Hg, a specialist investor based in the U.K in order to further enhance end-to-end capabilities.

Read the full release here.

Related Content:

News